Bio-Thera Solutions, Ltd

2:15 PM - 2:30 PM, Thursday, June 6, 2019 ・ Theater 1
Bio-Thera Solutions Ltd, a leading global biotechnology company in Guangzhou, China, is dedicated to researching and developing novel therapeutics for the treatment of cancer, autoimmune, cardiovascular diseases, and other serious unmet medical needs, as well as biosimilars for existing, branded biologics to treat a range of cancer and autoimmune diseases. A leader in next generation antibody discovery and engineering, the company has advanced five candidates into late stage clinical trials and has applied for marketing authorization for one candidate. In addition, the company has multiple promising candidates in early clinical trials and IND-enabling studies, focusing on innovative targets in immuno-oncology and autoimmune diseases. For more information, please visit www.bio-thera.com/en/ or follow us on Twitter (@bio_thera_sol) and wechat (Bio-Thera).
Ticker:
Not Provided.
Exchange:
Not Provided.
Company Type:
Company Website:
Company HQ State:
Not Provided.
Company HQ Country:
China
Year Founded:
2003
Main Therapeutic Focus:
Lead Product in Development:
BAT1706 (a bevacizumab biosimilar)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
11
Speaker
photo
Senior Vice President, Business Development
Bio-Thera Solutions, Ltd